February 15, 2021
Medical device maker Masimo is the latest company to develop a solution to help businesses, schools and other organizations reopen. Today, it announced the release of SafetyNet-OPEN, a web and mobile app solution that can screen, trace and manage users as they return to work.
The back-to-work tool builds upon Masimo's SafetyNet remote monitoring system that was developed at the beginning of the...
October 5, 2020
Medtech company Masimo announced today that it is launching the Radius T Continuous Thermometer, a connected sensor system that can take a patient’s temperature over time in lieu of the manual process, for consumers.
The tool is able to send temperature readings and also warning alerts if there is a spike to a corresponding app. Users can customize the alerts and notifications functions. The app...
September 28, 2020
Medical device creator Masimo announced today its latest 510(k) clearance from the U.S. Food and Drug Administration for the Rad-G pulse oximeter.
The Rad-G is a handheld device that combines Masimo’s signal extraction technology (SET) pulse oximetry and respiration rate from the pleth (RRp) that can be used to spot-check or continually monitor.
It’s lightweight, handheld, and has a 24-hour...
September 15, 2020
Capsule Technologies, a medical device-maker (not to be confused with digital pharmacy Capsule), has just landed FDA 510(k) clearance for its new connected capnography-monitoring technology.
Called Vitals Plus monitoring solution, it was created to incorporate Masimo's NomoLine ISA CO2, and designed to keep track of a patient's end-tidal carbon dioxide, respiratory rate, and fractional inspired...
August 31, 2020
Connected care company Masimo has landed and expanded FDA clearance for its O3 Regional Oximeter, for both somatic applications and monitoring changes in the cerebral hemoglobin.
It specifically monitors somatic tissue oxygenation saturation, and can detect changes in a patient’s hemoglobin, oxyhemoglobin and deoxyhemoglobin.
According to the company, its tool differs from peripheral pulse...
July 30, 2020
The WNBA is teaming up with the Oura smart ring for the upcoming season as part of the initiative to prioritize the players' and league staff’s health, safety and privacy.
This comes just a month after the NBA announced it too would provide Oura rings to all teams and league staff members.
Today the NBA announced another partnership, this time with Masimo, to supply players, coaches and staff...
June 29, 2020
Masimo, a medical technology company, announced today its device aimed at reducing the symptoms associated with opioid withdrawal.
The device, called Bridge, is a wearable, single-patient-use, percutaneous neurostimulator which is situated behind the ear. It applies electrical impulses to the cranial nerves around the ear, which can reduce neuron activity and reduce opioid withdrawal symptoms,...
January 28, 2019
This morning medical device company Masimo announced FDA clearance for the measurement of respiration rate from a photoplethysmogram (RRp), so that it may now be used on the MightSat Rx finger pulse oximeter. The latest clearance also means the technology can be used at home by patients.
The new technology will be able to calculate a user’s respiration rate, which is the count of breaths per...
January 22, 2019
Laid to rest. A longstanding legal dispute between Apple and Valencell over infringement on four patents and deceptive trade practices was quietly put to bed last year. The two companies submitted their dismissal to the US District Court North Carolina in September, with no other details on how the settlement shook out.
When this case (and a similar one against Fitbit) was first filed in early...
December 3, 2018
The FDA has announced the winners of the opioid addiction innovation challenge the agency launched last May. Out of more than 250 applications from medical device developers, the FDA selected eight winners.
"While these products will not automatically receive marketing authorization from the FDA, the device developers will receive increased interaction with CDRH experts, guidance for clinical...